OVARIAN SQUAMOUS CELL CARCINOMA
Clinical trials for OVARIAN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Matched conditions: OVARIAN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for rare ovarian cancer: immunotherapy drug tested in small trial
Disease control OngoingThis study tests the drug pembrolizumab in 21 women with a rare and advanced form of ovarian cancer called squamous cell carcinoma. The goal is to see if the drug can shrink tumors or slow the cancer's growth. Participants receive the drug intravenously, and the study tracks how …
Matched conditions: OVARIAN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Niigata University Medical & Dental Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC